Literature DB >> 12435581

Isolation of embryonic stem-like cells from equine blastocysts and their differentiation in vitro.

Shigeo Saito1, Hideyo Ugai, Ken Sawai, Yusuke Yamamoto, Akira Minamihashi, Kahori Kurosaka, Yoshiro Kobayashi, Takehide Murata, Yuichi Obata, Kazunari Yokoyama.   

Abstract

Embryonic stem (ES) cells are pluripotent cells with the potential capacity to generate any type of cell. We describe here the isolation of pluripotent ES-like cells from equine blastocysts that have been frozen and thawed. Our two lines of ES-like cells (E-1 and E-2) appear to maintain a normal diploid karyotype indefinitely in culture in vitro and to express markers that are characteristic of ES cells from mice, namely, alkaline phosphatase, stage-specific embryonic antigen-1, STAT-3 and Oct 4. After culture of equine ES-like cells in vitro for more than 17 passages, some ES-like cells differentiated to neural precursor cells in the presence of basic fibroblast growth factor (bFGF), epidermal growth factor and platelet-derived growth factor. We also developed a protocol that resulted in the differentiation of ES-like cells in vitro to hematopoietic and endothelial cell lineages in response to bFGF, stem cell factor and oncostatin M. Our observations set the stage for future developments that may allow the use of equine ES-like cells for the treatment of neurological and hematopoietic disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435581     DOI: 10.1016/s0014-5793(02)03550-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  28 in total

Review 1.  Stem cells in the umbilical cord.

Authors:  Mark L Weiss; Deryl L Troyer
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 2.  The pursuit of ES cell lines of domesticated ungulates.

Authors:  Neil C Talbot; Le Ann Blomberg
Journal:  Stem Cell Rev       Date:  2008-07-09       Impact factor: 5.739

3.  Equivalency of buffalo (Bubalus bubalis) embryonic stem cells derived from fertilized, parthenogenetic, and hand-made cloned embryos.

Authors:  Musharifa Muzaffar; Naresh L Selokar; Karn P Singh; Mohammad Zandi; Manoj K Singh; Riaz A Shah; Manmohan S Chauhan; Suresh K Singla; Prabhat Palta; Radheysham Manik
Journal:  Cell Reprogram       Date:  2012-05-14       Impact factor: 1.987

Review 4.  Derivation and induction of the differentiation of animal ES cells as well as human pluripotent stem cells derived from fetal membrane.

Authors:  Shigeo Saito; Kazunari Yokoyama; Tomoharu Tamagawa; Isamu Ishiwata
Journal:  Hum Cell       Date:  2005-09       Impact factor: 4.174

5.  Embryonic stem cells and iPS cells: sources and characteristics.

Authors:  Catherine H Hackett; Lisa A Fortier
Journal:  Vet Clin North Am Equine Pract       Date:  2011-06-16       Impact factor: 1.792

6.  Generation and characterization of leukemia inhibitory factor-dependent equine induced pluripotent stem cells from adult dermal fibroblasts.

Authors:  Deanne J Whitworth; Dmitry A Ovchinnikov; Jane Sun; Patrick R J Fortuna; Ernst J Wolvetang
Journal:  Stem Cells Dev       Date:  2014-04-01       Impact factor: 3.272

Review 7.  The promise of stem cell research in pigs and other ungulate species.

Authors:  Bhanu Prakash V L Telugu; Toshihiko Ezashi; R Michael Roberts
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

Review 8.  Wharton's jelly-derived cells are a primitive stromal cell population.

Authors:  Deryl L Troyer; Mark L Weiss
Journal:  Stem Cells       Date:  2007-12-06       Impact factor: 6.277

9.  Selection of appropriate isolation method based on morphology of blastocyst for efficient derivation of buffalo embryonic stem cells.

Authors:  R Kumar; S P S Ahlawat; M Sharma; O P Verma; G Sai Kumar; G Taru Sharma
Journal:  Cytotechnology       Date:  2013-04-04       Impact factor: 2.058

Review 10.  Concepts for the clinical use of stem cells in equine medicine.

Authors:  Thomas G Koch; Lise C Berg; Dean H Betts
Journal:  Can Vet J       Date:  2008-10       Impact factor: 1.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.